Table 3.
Plan 1 as reference |
||||
---|---|---|---|---|
Plan 2 | Plan 3 | Plan 4 | ||
Tumor | BED (Gy) | -4.0±6.2 (p=0.05) | 0.9±7.6 (p=0.69) | 1.0±7.2 (p=0.63) |
NTD (Gy) | -3.3±5.1 (p=0.05) | 0.7±6.3 (p=0.69) | 0.9±6.0 (p=0.63) | |
Mean dose (Gy) | -0.7±1.1 (p=0.05) | 0.2±1.4 (p=0.70) | 0.2±1.3 (p=0.62) | |
Lung | BED (Gy) | -1.9±1.2 (p<0.01) | -3.1±1.6 (p<0.01) | -3.5±2.1 (p<0.01) |
NTD (Gy) | -1.6±1.0 (p<0.01) | -2.6±1.3 (p<0.01) | -2.9±1.8 (p<0.01) | |
Mean dose (Gy) | -0.8±0.5 (p<0.01) | -1.5±0.8 (p<0.01) | -1.6±1.0 (p<0.01) | |
V20 (%) | -1.5±1.0 (p<0.01) | -2.7±1.4 (p=0.01) | -2.8±1.8 (p<0.01) | |
Ipsilateral Lung | BED (Gy) | -3.4±2.0 (p<0.01) | -5.4±2.9 (p<0.01) | -6.2±3.9 (p<0.01) |
NTD (Gy) | -2.8±1.6 (p<0.01) | -4.5±2.4 (p<0.01) | -5.2±3.3 (p<0.01) | |
Mean dose (Gy) | -0.9±1.3 (p=0.04) | -2.1±1.3 (p<0.01) | -2.5±1.9 (p<0.01) | |
V20 (%) | -2.7±1.7 (p<0.01) | -4.9±2.6 (p<0.01) | -5.2±3.7 (p<0.01) |